Residual Breast Cancer Diagnosed by MRI in Patients Receiving Neoadjuvant Chemotherapy with and without Bevacizumab

PURPOSE: To investigate the impact of anti-angiogenic therapy with bevacizumab on pathological response and the diagnostic performance of MRI in breast cancer patients. METHODS: Thirty-six patients (age 31-69) with breast cancer were included. Sixteen patients received neoadjuvant chemotherapy (NAC)...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Bahri, Shadfar, Chen, Jeon-Hor, Mehta, Rita S., Carpenter, Philip M., Nie, Ke, Kwon, Soon-Young, Yu, Hon J., Nalcioglu, Orhan, Su, Min-Ying
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2009
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2786305/
https://ncbi.nlm.nih.gov/pubmed/19333654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-009-0441-5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi